✦ LIBER ✦

Efficacy and safety of entecavir in lamivudine-refractory patients with chronic hepatitis B: Randomized controlled trial in Japanese patients

✍ Scribed by Fumitaka Suzuki; Joji Toyoda; Yoshiaki Katano; Michio Sata; Mitsuhiko Moriyama; Fumio Imazeki; Masayoshi Kage; Taku Seriu; Masao Omata; Hiromitsu Kumada

Book ID: 108951879
Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 152 KB
Volume: 23
Category: Article
ISSN: 0815-9319
DOI: 10.1111/j.1440-1746.2008.05455.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term efficacy of entecavir in adefo

Long-term efficacy of entecavir in adefovir-refractory chronic hepatitis B patients with prior lamivudine resistance

✍ J. W. Park; H. S. Kim; D. D. Seo; J. S. Jang; W. G. Shin; K. H. Kim; M. K. Jang; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB

Efficacy and safety of entecavir compare

Efficacy and safety of entecavir compared to lamivudine in nucleoside-naïve patients with chronic hepatitis B: a randomized double-blind trial in China

✍ Guangbi Yao; Chengwei Chen; Weilun Lu; Hong Ren; Deming Tan; Yuming Wang; Daozhe 📂 Article 📅 2007 🏛 Springer-Verlag 🌐 English ⚖ 223 KB

Efficacy and safety of entecavir compare

Efficacy and safety of entecavir compared to lamivudine in nucleoside-naïve patients with chronic hepatitis B: a randomized double-blind trial in China

✍ Guangbi Yao; Chengwei Chen; Weilun Lu; Hong Ren; Deming Tan; Yuming Wang; Daozhe 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 89 KB

Entecavir for the treatment of lamivudin

Entecavir for the treatment of lamivudine-refractory chronic hepatitis B patients in China

✍ Guangbi Yao; Xiaqiu Zhou; Daozheng Xu; Baoen Wang; Hong Ren; Jessica Liu; Dong X 📂 Article 📅 2007 🏛 Springer-Verlag 🌐 English ⚖ 318 KB

Low efficacy of entecavir therapy in ade

Low efficacy of entecavir therapy in adefovir-refractory hepatitis B patients with prior lamivudine resistance

✍ S. W. Cho; K. H. Koh; J. Y. Cheong; M. H. Lee; S. P. Hong; W. D. Yoo; S.-O. Kim 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

Efficacy of thymosin α1 in patients with

Efficacy of thymosin α1 in patients with chronic hepatitis B: A randomized, controlled trial

✍ Rong-Nan Chien; Yun-Fan Liaw; Tse-Ching Chen; Chau-Ting Yeh; I.-Shyan Sheen 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 107 KB 👁 1 views

Thymosin ␣ 1 (T␣) is an immune modifier that has been shown in a pilot study to be effective for chronic hepatitis B; this requires confirmation. Ninety-eight patients with clinicopathologically proven chronic hepatitis B were randomly allocated to 3 groups: 1) group A received a 26-week course of T